INVEST in GREECE agency

Περιοδική έκδοση

ATHENS

Μάιος 2010

EDITORIAL

Christos AlexakisCEOInvest in Greece Agency

Without a doubt, Greece is faced with severe challenges as it navigates the turbulence of today’s environment. And although the hurdles are many, we are confident that the Greek government, and the Greek people, are prepared to overcome the obstacles that we confront.

Today’s difficulties are being met with a sense of realism and responsibility by the Greek government. Indeed, it is a time to proceed with deep structural reforms resulting in a more healthy, competitive, and productive economy.

At the same time, the Ministry of Economy, Competitiveness and Shipping is instituting a sweeping package of new initiatives that address the underlying needs of Greek entrepreneurs, business people, and investors. At the heart of these initiatives is the necessity to streamline every phase of setting up and operating a business in Greece, so that productive investments proceed unhindered and with the full support of the State.

The robust interest in Greece’s energy market is producing a flurry of activity in energy production, manufacturing, new aeolic parks, new government programmes and policies, as well as new legislation designed to streamline the RES licensing procedure.

The shipbuilding group Abu Dhabi Mar (ADM) announced its decision to invest in Greek shipbuilding through the acquisition of a majority stake in the Hellenic Shipyards S.A. at Skaramangas. In addition, the State of Qatar has expressed its intention to commit to a major, 3 billion Euro investment in the Industrial region of Astakos.

In May 2010, Navarino Dunes, the first phase of the Costa Navarino development project, will proudly open its doors to the public on the ancient shores of Messinia in the Peloponnese- the culmination of 15 years of vision, meticulous planning, and breakthrough design.

Operating from headquarters in Athens, Greece and Charlottesville, Virginia since 1993, Biovista has quickly become a driving force for technological innovation in the fields of biotechnology and drug repositioning around the world.